Section Arrow
LSTA.NASDAQ
- Lisata Therapeutics
Quotes are at least 15-min delayed:2025/03/28 05:26 EDT
Last
 2.4104
-0.0196 (-0.81%)
Day High 
2.44 
Prev. Close
2.43 
1-M High
2.62 
Volume 
1.86K 
Bid
1.2
Ask
2.55
Day Low
2.3311 
Open
2.44 
1-M Low
2.05 
Market Cap 
20.95M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.34 
20-SMA 2.32 
50-SMA 2.58 
52-W High 4.2 
52-W Low 2.05 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.40/-2.54
Enterprise Value
21.25M
Balance Sheet
Book Value Per Share
3.43
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.00M
Operating Revenue Per Share
--
Created with Highstock 5.0.121-min Chart10:0013:002.3252.352.3752.42.4252.45etnet.com.hk@copyright
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed:2025/03/28 05:26 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.